Direct-acting antivirals for acute HCV: how short can we go?

Affiliations

¹ Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia. Electronic address: mmartinello@kirby.unsw.edu.au.
² Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia.

Comment

Marianne Martinello et al. Lancet Gastroenterol Hepatol. 2017 May.

. 2017 May;2(5):316-318.

doi: 10.1016/S2468-1253(17)30043-2. Epub 2017 Feb 28.

¹ Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia. Electronic address: mmartinello@kirby.unsw.edu.au.
² Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia.

No abstract available

Comment on

Ledipasvir-sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial.
Rockstroh JK, Bhagani S, Hyland RH, Yun C, Dvory-Sobol H, Zheng W, Brainard DM, Ingiliz P, Lutz T, Boesecke C, Nelson M. Rockstroh JK, et al. Lancet Gastroenterol Hepatol. 2017 May;2(5):347-353. doi: 10.1016/S2468-1253(17)30003-1. Epub 2017 Mar 1. Lancet Gastroenterol Hepatol. 2017. PMID: 28397698 Clinical Trial.